$61.07
3.09% day before yesterday
NYSE, Jun 18, 10:27 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$61.07
-1.27 2.04% 1M
+32.52 113.91% 6M
+36.89 152.56% YTD
+36.28 146.35% 1Y
+50.98 505.25% 5Y
+51.27 523.16% 10Y
+51.27 523.16% 20Y
NYSE, Closing price Wed, Jun 18 2025
+1.83 3.09%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $13.67b
Enterprise Value $13.35b
P/E (TTM) P/E ratio 92.53
EV/FCF (TTM) EV/FCF 56.43
EV/Sales (TTM) EV/Sales 7.48
P/S ratio (TTM) P/S ratio 7.66
P/B ratio (TTM) P/B ratio 24.86
Revenue growth (TTM) Revenue growth 85.99%
Revenue (TTM) Revenue $1.78b
EBIT (operating result TTM) EBIT $115.57m
Free Cash Flow (TTM) Free Cash Flow $236.51m
Cash position $322.67m
EPS (TTM) EPS $0.66
P/E forward 90.38
P/S forward 5.82
EV/Sales forward 5.68
Short interest 33.78%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,872 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Hims & Hers Health Inc. forecast:

5x Buy
36%
7x Hold
50%
2x Sell
14%

Analyst Opinions

14 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
36%
Hold
50%
Sell
14%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,784 1,784
86% 86%
100%
- Direct Costs 410 410
143% 143%
23%
1,375 1,375
74% 74%
77%
- Selling and Administrative Expenses 1,259 1,259
58% 58%
71%
- Research and Development Expense - -
-
-
138 138
2,698% 2,698%
8%
- Depreciation and Amortization 22 22
115% 115%
1%
EBIT (Operating Income) EBIT 116 116
2,214% 2,214%
6%
Net Profit 164 164
7,096% 7,096%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Positive
Seeking Alpha
about 15 hours ago
The bulls have well defended Hims & Hers' recovery from the April 2025 bottom (near to our fair value estimates), thanks to the growing adoption of its personalized healthcare offerings. These have directly triggered the growing subscriber base/ Revenue per Average Subscriber, with the improved manufacturing/ operating scale contributing to the richer profit margins. This is significantly aided...
Positive
The Motley Fool
one day ago
Hims & Hers (HIMS 0.74%) has seen growth skyrocket in the last five years and the market may still be underestimating the company's potential. We look at Hims & Hers' growth potential and profitability in this video and give you an idea of the potentially massive returns ahead.
Positive
The Motley Fool
3 days ago
When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that power your returns, but finding a few stocks that can be massive winners over time.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today